A venture philanthropy group is funding an initiative to find digital data indicators of early onset of Alzheimer’s disease and other forms of dementia. . . . → Read More: Alzheimer’s Digital Biomarkers Project Gains New Funds
|
|||||
|
       
  |
A start-up company creating synthetic blood vessels for transplants, based on research in materials science and cell biology, is raising $2.2 million in seed funds. . . . → Read More: Synthetic Blood Vessel Maker Gains $2.2M in Seed Funds 
A developer of treatments for people with amyotrophic lateral sclerosis, or ALS, is raising $135 million in its third venture financing round. . . . → Read More: ALS Drug Maker Gains $135M in New Funds 
Venture funding for Black-owned start-ups in the U.S. rose to record levels in the first half of 2021, but the percentage of total funding remains low. . . . → Read More: Infographic – 2021 Black Start-Up Funding Rises 
A biotechnology company developing cancer therapies with natural killer cells in the immune system is raising $172 million in its second venture round. . . . → Read More: Immune Cell Cancer Biotech Gains $172M in New Funds 
A new challenge competition aims to build a distributed network of facilities to design, develop, and manufacture RNA-based biologic products. . . . → Read More: $60M Challenge Seeks RNA Bio-Production Network 
A biotechnology company says it discovers therapies with the gene-editing technique Crispr to carry out a wider range of precise genomic corrections. . . . → Read More: Precision Gene-Editing Biotech Gains $200M in New Funds  Comments are closed  Finance, New products  biomedical, biotechnology, entrepreneurs, equity, genomics, investment, life sciences, pharmaceuticals, university 
Venture capital financing broke global records in the second quarter of 2021, with investments in the U.S. accounting for nearly half of all dollars invested. . . . → Read More: Infographic – U.S. Leads Record Q2 Venture Funding One comment - (Comments are closed) Finance economics, equity, investment, statistics, venture capital 
A new enterprise discovering treatments for neurodegenerative diseases is merging with another start-up and raising $73 million its first venture round. . . . → Read More: Neuro Disease Start-Up Raises $73M in Early Funds One comment - (Comments are closed) Finance, New products biomedical, biotechnology, entrepreneurs, equity, Europe, genomics, investment, life sciences, merger, pharmaceuticals, university, venture capital 
Since mid-May, NBI rose steadily, closing at 5,148 by the end of June, a gain of nine percent for the quarter and eight percent for the year. . . . → Read More: Infographic – Biotech Index Rebounds in Q2 |
||||
|
Copyright © 2021 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||